Cargando…
The evaluation of cost-of-illness due to use of cost-of-illness-based chemicals
OBJECTIVES: This study is conducted to estimate the cost paid by the public suffering from disease possibly caused by chemical and to examine the effect on public health. METHODS: Cost-benefit analysis is an important factor in analysis and decision-making and is an important policy decision tool in...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Environmental Health and Toxicology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540129/ https://www.ncbi.nlm.nih.gov/pubmed/26206367 http://dx.doi.org/10.5620/eht.s2015006 |
_version_ | 1782386200544280576 |
---|---|
author | Hong, Jiyeon Lee, Yongjin Lee, Geonwoo Lee, Hanseul Yang, Jiyeon |
author_facet | Hong, Jiyeon Lee, Yongjin Lee, Geonwoo Lee, Hanseul Yang, Jiyeon |
author_sort | Hong, Jiyeon |
collection | PubMed |
description | OBJECTIVES: This study is conducted to estimate the cost paid by the public suffering from disease possibly caused by chemical and to examine the effect on public health. METHODS: Cost-benefit analysis is an important factor in analysis and decision-making and is an important policy decision tool in many countries. Cost-of-illness (COI), a kind of scale-based analysis method, estimates the potential value lost as a result of illness as a monetary unit and calculates the cost in terms of direct, indirect and psychological costs. This study estimates direct medical costs, transportation fees for hospitalization and outpatient treatment, and nursing fees through a number of patients suffering from disease caused by chemicals in order to analyze COI, taking into account the cost of productivity loss as an indirect cost. RESULTS: The total yearly cost of the diseases studied in 2012 is calculated as 77 million Korean won (KRW) per person. The direct and indirect costs being 52 million KRW and 23 million KRW, respectively. Within the total cost of illness, mental and behavioral disability costs amounted to 16 million KRW, relevant blood immunological parameters costs were 7.4 million KRW, and disease of the nervous system costs were 6.7 million KRW. CONCLUSIONS: This study reports on a survey conducted by experts regarding diseases possibly caused by chemicals and estimates the cost for the general public. The results can be used to formulate a basic report for a social-economic evaluation of the permitted use of chemicals and limits of usage. |
format | Online Article Text |
id | pubmed-4540129 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | The Korean Society of Environmental Health and Toxicology |
record_format | MEDLINE/PubMed |
spelling | pubmed-45401292015-08-21 The evaluation of cost-of-illness due to use of cost-of-illness-based chemicals Hong, Jiyeon Lee, Yongjin Lee, Geonwoo Lee, Hanseul Yang, Jiyeon Environ Health Toxicol Brief Report OBJECTIVES: This study is conducted to estimate the cost paid by the public suffering from disease possibly caused by chemical and to examine the effect on public health. METHODS: Cost-benefit analysis is an important factor in analysis and decision-making and is an important policy decision tool in many countries. Cost-of-illness (COI), a kind of scale-based analysis method, estimates the potential value lost as a result of illness as a monetary unit and calculates the cost in terms of direct, indirect and psychological costs. This study estimates direct medical costs, transportation fees for hospitalization and outpatient treatment, and nursing fees through a number of patients suffering from disease caused by chemicals in order to analyze COI, taking into account the cost of productivity loss as an indirect cost. RESULTS: The total yearly cost of the diseases studied in 2012 is calculated as 77 million Korean won (KRW) per person. The direct and indirect costs being 52 million KRW and 23 million KRW, respectively. Within the total cost of illness, mental and behavioral disability costs amounted to 16 million KRW, relevant blood immunological parameters costs were 7.4 million KRW, and disease of the nervous system costs were 6.7 million KRW. CONCLUSIONS: This study reports on a survey conducted by experts regarding diseases possibly caused by chemicals and estimates the cost for the general public. The results can be used to formulate a basic report for a social-economic evaluation of the permitted use of chemicals and limits of usage. The Korean Society of Environmental Health and Toxicology 2015-06-12 /pmc/articles/PMC4540129/ /pubmed/26206367 http://dx.doi.org/10.5620/eht.s2015006 Text en Copyright © 2015 The Korean Society of Environmental Health and Toxicology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Brief Report Hong, Jiyeon Lee, Yongjin Lee, Geonwoo Lee, Hanseul Yang, Jiyeon The evaluation of cost-of-illness due to use of cost-of-illness-based chemicals |
title | The evaluation of cost-of-illness due to use of cost-of-illness-based chemicals |
title_full | The evaluation of cost-of-illness due to use of cost-of-illness-based chemicals |
title_fullStr | The evaluation of cost-of-illness due to use of cost-of-illness-based chemicals |
title_full_unstemmed | The evaluation of cost-of-illness due to use of cost-of-illness-based chemicals |
title_short | The evaluation of cost-of-illness due to use of cost-of-illness-based chemicals |
title_sort | evaluation of cost-of-illness due to use of cost-of-illness-based chemicals |
topic | Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540129/ https://www.ncbi.nlm.nih.gov/pubmed/26206367 http://dx.doi.org/10.5620/eht.s2015006 |
work_keys_str_mv | AT hongjiyeon theevaluationofcostofillnessduetouseofcostofillnessbasedchemicals AT leeyongjin theevaluationofcostofillnessduetouseofcostofillnessbasedchemicals AT leegeonwoo theevaluationofcostofillnessduetouseofcostofillnessbasedchemicals AT leehanseul theevaluationofcostofillnessduetouseofcostofillnessbasedchemicals AT yangjiyeon theevaluationofcostofillnessduetouseofcostofillnessbasedchemicals AT hongjiyeon evaluationofcostofillnessduetouseofcostofillnessbasedchemicals AT leeyongjin evaluationofcostofillnessduetouseofcostofillnessbasedchemicals AT leegeonwoo evaluationofcostofillnessduetouseofcostofillnessbasedchemicals AT leehanseul evaluationofcostofillnessduetouseofcostofillnessbasedchemicals AT yangjiyeon evaluationofcostofillnessduetouseofcostofillnessbasedchemicals |